Exclusive

Publication

Byline

Location

Court asks govt to retest samples of Ghaziabad-based firm's polio vaccine

New Delhi, Jan. 14 -- The Ghaziabad district court has asked the government to re-test samples of polio vaccines made by Ghaziabad-based Bio-Med Pvt. Ltd after the company contested results of a test ... Read More


Govt moves SC for compensation in J&J faulty hip implant cases

New Delhi, Jan. 12 -- The government on Friday will file an affidavit in the Supreme Court urging the court to direct US-based pharmaceutical giant Johnson and Johnson Pvt. Ltd to compensate trouble-s... Read More


Govt moves SC for compensation in Johnson & Johnson 'faulty' hip implant cases

New Delhi, Jan. 11 -- The government on Friday will file an affidavit in the Supreme Court urging the court to direct US-based pharmaceutical giant Johnson and Johnson Pvt. Ltd to compensate trouble-s... Read More


Government to tweak solatium clause in clinical trials

New Delhi, Jan. 11 -- The government has decided to remove a clause in the draft clinical trials rules that mandate the sponsor (the entity initiating the trial) to pay 60% of compensation upfront in ... Read More


Faulty hip implants: J&J submits framework used in US to compensate patients in India

New Delhi, Jan. 9 -- In a move that shows Johnson & Johnson's intent to compensate patients in India, the company on Wednesday submitted a framework it had used in the US for compensating patients. Ho... Read More


J&J representatives to meet compensation panel tomorrow

New Delhi, Jan. 8 -- Representatives of American medical devices maker Johnson and Johnson (J&J) Pvt. Ltd will attend a meeting of the central expert committee that devised the compensation formula fo... Read More


NHAI may drop BOT, focus on hybrid annuity, EPC model

Mumbai, Jan. 7 -- With liquidity tightening in the banking system and funding becoming scarce for large infrastructure projects, industry experts estimate that the national roads authority will more o... Read More


New drug price cap exemptions pitch DoP against health ministry

New Delhi, Jan. 6 -- The ministry of health and family welfare and the department of pharmaceuticals (DoP) seem to be heading for a face off following the DoP's decision to remove price caps on orphan... Read More


Govt move to exempt key foreign-made drugs from price control draws flak

New Delhi, Jan. 5 -- Domestic drugmakers and civil rights activists on Friday criticized the government over its decision to exempt foreign-made orphan and innovative drugs from price control, complai... Read More


GOVT MAY OFFER MORE RELIEF TO FAULTY J&J HIP IMPLANT VICTIMS

New Delhi, Jan. 4 -- The government may tweak its formula for compensation in the Johnson and Johnson (J&J) faulty hip implant case to pacify aggrieved victims. The central expert committee that devi... Read More